Shares of BioLife Solutions BLFS rose 9.7% in after-market trading after the company reported Q4 results.
Quarterly Results
Earnings per share were down 0.00% year over year to ($0.01), which beat the estimate of ($0.02).
Revenue of $14,726,000 rose by 77.53% year over year, which beat the estimate of $13,500,000.
Guidance
BioLife Solutions hasn't issued any earnings guidance for the time being.
Revenue guidance hasn't been issued by the company for now.
Details Of The Call
Date: Mar 22, 2021
Time: 04:30 PM
ET Webcast URL: https://edge.media-server.com/mmc/p/mzaka3uq
Technicals
Company's 52-week high was at $47.22
Company's 52-week low was at $8.29
Price action over last quarter: Up 25.63%
Company Overview
BioLife Solutions Inc is active in the healthcare segment. The company is engaged in the developing, manufacturing and marketing a portfolio of biopreservation tools and services for cells, tissues and organs, including clinical grade cell and tissue hypothermic storage and cryopreservation freeze media and a related cloud, hosted biologistics cold chain management application for shippers. The company's product offerings include hypothermic storage and cryopreservation freeze media products for cells, tissues, and organs.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.